Home > Insider Trading > Filing (0001209191-22-010362)

Filing Details

Accession Number:: 0001209191-22-010362
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-02-16 19:54:59
Reporting Period:: 2021-06-11

Accepted Time:: 2022-02-16 19:54:59
Original Submission Date:: 2021-06-14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1124140	Exact Sciences Corp	EXAS	Services-Medical Laboratories (8071)	204782291

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1839989	Sarah Condella	C/O Exact Sciences Corp. 5505 Endeavor Lane Madison WI 53719	Svp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-06-11	5,050	$5.03	75,930	No	4	M	Direct
Common Stock	Acquisiton	2021-06-11	8,052	$21.68	83,982	No	4	M	Direct
Common Stock	Acquisiton	2021-06-14	1,950	$5.03	85,932	No	4	M	Direct
Common Stock	Disposition	2021-06-14	2,945	$121.88	82,987	No	4	S	Direct
Common Stock	Disposition	2021-06-14	1,470	$122.78	81,517	No	4	S	Direct
Common Stock	Disposition	2021-06-14	885	$123.58	80,632	No	4	S	Direct
Common Stock	Disposition	2021-06-14	150	$124.42	80,482	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-06-11	5,050	$5.03	5,050	$5.03
Common Stock	Stock Option (right to buy)	Disposition	2021-06-11	8,052	$21.68	8,052	$21.68
Common Stock	Stock Option (right to buy)	Disposition	2021-06-14	1,950	$5.03	1,950	$5.03

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,850	2026-02-28	No	4	M	Direct
21,948	2027-02-23	No	4	M	Direct
3,900	2026-02-28	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,922	Indirect	Held in 401(k) Plan

Footnotes

The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into in February 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.37 to $122.36, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.37 to $123.11, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.23 to $123.80, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
These options vested and became exercisable in full on February 28, 2020.
These options vested and became exercisable in full on February 23, 2021.